P-cadherin cooperates with insulin-like growth factor-1 receptor to promote metastatic signaling of gonadotropin-releasing hormone in ovarian cancer via p120 catenin
- 14 February 2011
- journal article
- Published by Springer Nature in Oncogene
- Vol. 30 (26) , 2964-2974
Abstract
Gonadotropin-releasing hormone (GnRH) is a potent prometastatic factor in ovarian cancer, but the intracellular signaling events are not well understood. The classical Gα(q)-phospholipase C signal transduction pathway known to operate in the pituitary is not involved in GnRH actions at non-pituitary targets. Here we showed that GnRH treatment of ovarian cancer cells led to a rapid and remarkable tyrosine phosphorylation of p120 catenin (p120(ctn)), which was mediated by P-cadherin. The use of P-cadherin small interfering RNA or neutralizing antibodies to inhibit P-cadherin expression and function resulted in diminished p120(ctn) activation, confirming that the effect was P-cadherin specific. On exploring how P-cadherin, which lacks intrinsic kinase activity, might regulate the activation of p120(ctn), we found that P-cadherin could induce the ligand-independent activation of insulin-like growth factor-1 receptor (IGF-1R). Inhibition of IGF-1R expression or its activity significantly inhibited GnRH-induced p120(ctn) activation, and the subsequent cell migration and invasion. In addition, we showed that IGF-1R regulation by P-cadherin was associated with complex formation between IGF-1R and P-cadherin, and this regulation was also observed to be in vivo correlated with metastasis. Furthermore, using a mouse model of ovarian cancer metastasis, GnRH receptor knockdown was shown to diminish peritoneal dissemination of tumors and ascites formation. These findings suggest for the first time that GnRH can initiate an outside-in p120(ctn) signal transduction through the cross-talk between P-cadherin and IGF-1R, thus providing a novel molecular mechanism by which GnRH may control the high level of aggressiveness and invasion and metastasis potential that are characteristic of ovarian cancer.Keywords
This publication has 37 references indexed in Scilit:
- Relationships of Insulin-Like Growth Factor-1 Receptor and Epidermal Growth Factor Receptor Expression to Clinical Outcomes in Patients with Colorectal CancerOncology, 2008
- p70 S6 Kinase Promotes Epithelial to Mesenchymal Transition through Snail Induction in Ovarian Cancer CellsCancer Research, 2008
- Jagged-1 and Notch3 Juxtacrine Loop Regulates Ovarian Tumor Growth and AdhesionCancer Research, 2008
- Gonadotropin-Releasing Hormone Promotes Ovarian Cancer Cell Invasiveness through c-Jun NH2-Terminal Kinase–Mediated Activation of Matrix Metalloproteinase (MMP)-2 and MMP-9Cancer Research, 2006
- p120 Catenin Is Required for Growth Factor–dependent Cell Motility and Scattering in Epithelial CellsMolecular Biology of the Cell, 2003
- Rho GTPases in cell biologyNature, 2002
- Identification of the cadherin subtypes present in the human peritoneum and endometriotic lesions: Potential role for P‐cadherin in the development of endometriosisMolecular Reproduction and Development, 2002
- Constitutive and conditional cadherin expression in cultured human ovarian surface epithelium: Influence of family history of ovarian cancerInternational Journal of Cancer, 1999
- G-Protein and Tyrosine Kinase Receptor Cross-Talk in Rat Aortic Smooth Muscle Cells: Thrombin- and Angiotensin II-Induced Tyrosine Phosphorylation of Insulin Receptor Substrate-1 and Insulin-like Growth Factor 1 ReceptorBiochemical and Biophysical Research Communications, 1996
- Gonadotropin releasing hormone binding sites in human epithelial ovarian carcinomataEuropean Journal of Cancer and Clinical Oncology, 1989